Autolus Therapeutics plc American Depositary Share (AUTL)
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Autolus Therapeutics plc American Depositary Share (AUTL) is listed on Nasdaq, where it has traded since June 22, 2018.
- Listed On
- Nasdaq
- Listed Since
- June 22, 2018
- Employees
- 752
- Market Cap
- $341M
About Autolus Therapeutics plc American Depositary Share
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8. Company's T cell programming technologies tailors therapies to address the specific disease targeting and introduce new programming modules into a patient's T cells to give those T cells improved properties to recognize target cells and overcome fundamental disease defense mechanisms.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 83 institutions reported holding AUTL, with 131.8 million shares worth $211.3 million in aggregate. The largest reported holder was Mak Capital One, with 33.6 million shares worth $53.8 million. Of the 5 largest holders listed below, 1 reduced its position and 4 held their positions unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Mak Capital One | 33,621,487 | $54M | Unchanged |
| Blackstone | 20,485,611 | $33M | Unchanged |
| Syncona Portfolio | 16,640,720 | $27M | Unchanged |
| Armistice Capital | 15,000,000 | $24M | Reduced 5.06% |
| Tfg Asset Management GP | 9,500,000 | $15M | Unchanged |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is AUTL?
Autolus Therapeutics plc American Depositary Share (AUTL) is listed on Nasdaq, where it has traded since June 22, 2018.
Who are the largest institutional holders of AUTL?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of AUTL were Mak Capital One, Blackstone and Syncona Portfolio.
How many institutions own AUTL?
83 institutions reported a position in AUTL for the quarter ended June 30, 2026, worth $211.3 million in total.
Did institutions buy or sell AUTL last quarter?
Of the 5 largest reported holders, 1 reduced its position and 4 held their positions unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for AUTL.
Every reported institutional holder, plus insider and congressional trades in AUTL, on SentiSense.